Where does Talis Biomedical Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Talis Biomedical Corporation ranks #12,699 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Talis Biomedical Corporation hold?

Talis Biomedical Corporation holds 24 US utility patents granted between 2018 and 2025, spanning 11 technology areas.

What is Talis Biomedical Corporation's Innovation Score?

Talis Biomedical Corporation has an Innovation Score of 39.0 out of 100 (top 39% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Talis Biomedical Corporation focus on?

Talis Biomedical Corporation's top technology area is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE) with 13 patents, ranking #136 of 1,325 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is Talis Biomedical Corporation's patent grant rate increasing or decreasing?

Talis Biomedical Corporation's recent grant velocity is +500% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Talis Biomedical Corporation's patents?

Talis Biomedical Corporation's patents average 21.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Talis Biomedical Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Talis Biomedical Corporation

USPTO PatentsView assignee record - 24 granted patents across 11 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01L (Chemical OR Physical Laboratory Apparatus FOR General USE).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Talis ranks #12,699 of 49,997 tracked US assignees by granted-patent volume, with 24 patents across 11 technology areas.

#12,699
of 49,997 US assignees by volume: Top 39%
by Innovation Score (39.0/100): 21.0
avg claims per patent: +500%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12699 · US Corporation #12,699 · 24 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 24 grants
MID-PACK #12,699/49,997
PHOTO-FINISH Tactonic
CPC-FOCUS B01L · 11 areas
INNOV-THIN 39.0/100
CLAIMS-DENSE 21.0 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +500% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Tactonic Technologies, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Talis’s 39.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.1 pts (28%) Velocity 3.6 pts (9%) Breadth 11.7 pts (30%) Claim depth 12.6 pts (32%)

Qualcomm Incorporated · highest

85
Talis Biomedical · this assignee

39
3D Lighting… · lowest

7

What this shows Talis's Innovation Score is 39.0/100 (top 39% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Talis?

Each dot is one of Talis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Talis’s own 21.0 claims/patent is ABOVE the 18.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Talis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Talis's grants concentrate

Talis Biomedical Corporation is a focused PatentsView assignee: 11 CPC subclasses with 54.2% of grants classified under B01L (Chemical OR Physical Laboratory Apparatus FOR General USE). Peak complete grant year is 2020 (6 grants) versus a trough of 1 in 2018. By volume, Talis sits between Towa Corporation and The Allen Company, Inc..

Talis's three-year grant acceleration

Talis Biomedical Corporation shows 7 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Towa

24
Tripleblind Holdi…

24
TRW Automotive Sa…

24
Tactonic

24
Tecore

24
Telesign

24
Tensera Networks

24
The Allen

24
Talis Biomedical ◀

24

What this shows Talis holds 24 patents at rank #12,710, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Talis

By rank, the assignees closest to #12,710 in granted patent volume.

Leaders in B01L (Chemical OR Physical Laboratory Apparatus FOR General USE)

Other assignees with the most granted patents in Talis's primary technology class.

Talis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 39% higher than 61% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Talis Biomedical Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	4.2%
2019	2	8.3%
2020	6	25.0%
2021	5	20.8%
2022	1	4.2%
2023	2	8.3%
2024	4	16.7%
2025partial year	3	12.5%

Which technologies does Talis Biomedical Corporation patent most?

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 13

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 12

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 9

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 5

A61B - DIAGNOSIS; SURGERY; Identification 4

F16K - VALVES; TAPS; COCKS; ACTUATING-FLOATS; Devices FOR Venting OR Aerating 3

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 3

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 2

Y02A - Technologies FOR Adaptation TO Climate Change 2

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Talis Biomedical Corporation's patent record in context - here's where to go next.

Talis Biomedical Corporation's lead technology class is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), 54.2% of its portfolio - see every assignee active in that class. Explore B01L
Ranked #12,699 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Talis Biomedical Corporation against Towa Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.